Search PubMed⌕ Search

Biomedical subjects

B Nielsen

Publications and source records attributed to B Nielsen.

At least 19 recordsLinked to original sources

Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.

Extrapyramidal symptoms (EPS) are seen in 50-75% of patients treated with typical antipsychotics and are a cause of treatment failure in at least 30% of the patients. Using atypical antipsychotics, the EPS incidence is lower, but a low-dosage strategy using typical antipsychotics is also known to cause fewer EPS. What conclusions can be drawn for the daily clinical practice? A naturalistic study including all schizophrenic inpatients in a psychiatric ward (n=123) analysed the effects of treatment concerning positive/negative symptoms, EPS, number of days to re-hospitalization and inpatient-days in the year after baseline admittance, using atypical and typical antipsychotics as recommended by the Danish Society of Psychiatry. The incidence of EPS was significantly higher in patients who were treated with typical antipsychotics in relation to atypical antipsychotics (46% vs. 12%, P<0.001). Patients with EPS had significantly more negative symptoms and a poorer level of function at discharge. Nevertheless, no difference regarding re-hospitalization and inpatient-days was found, whether the patient was treated with typical or atypical antipsychotics. However, it is important to underline that patients treated with atypical oral antipsychotic do as well as patients on typical depot antipsychotics.

Adult↗

Enhanced cerebral CO2 reactivity during strenuous exercise in man.

Light and moderate exercise elevates the regional cerebral blood flow by approximately 20% as determined by ultrasound Doppler sonography (middle cerebral artery mean flow velocity; MCA V(mean)). However, strenuous exercise, especially in the heat, appears to reduce MCA V(mean) more than can be accounted for by the reduction in the arterial CO(2) tension (P(a)CO(2)). This study evaluated whether the apparently large reduction in MCA V(mean) at the end of exhaustive exercise relates to an enhanced cerebrovascular CO(2) reactivity. The CO(2) reactivity was evaluated in six young healthy male subjects by the administration of CO(2) as well as by voluntary hypo- and hyperventilation at rest and during exercise with and without hyperthermia. At rest, P(a)CO(2) was 5.1 +/- 0.2 kPa (mean +/- SEM) and MCA V(mean) 50.7 +/- 3.8 cm s(-1) and the relationship between MCA V(mean) and P(a)CO(2 )was linear (double-log slope 1.1 +/- 0.1). However, the relationship became curvilinear during exercise (slope 1.8 +/- 0.1; P < 0.01 vs. rest) and during exercise with hyperthermia (slope 2.3 +/- 0.3; P < 0.05 vs. control exercise). Accordingly, the cerebral CO(2) reactivity increased from 30.5 +/- 2.7% kPa(-1) at rest to 61.4 +/- 10.1% kPa(-1) during exercise with hyperthermia (P < 0.05). At exhaustion P(a)CO(2) decreased 1.1+/- 0.2 kPa during exercise with hyperthermia, which, with the determined cerebral CO(2) reactivity, accounted for the 28 +/- 10% decrease in MCA V(mean). The results suggest that during exercise changes in cerebral blood flow are dominated by the arterial carbon dioxide tension.

Adult↗

Elevations in core and muscle temperature impairs repeated sprint performance.

AIM: The present study investigated the effects of hyperthermia on intermittent exercise and repeated sprint performance. METHODS: Seven men completed 40 min of intermittent cycling comprising of 15 s exercise (306 +/- 22 W) and 15 s rest periods (0 W) followed by 5 x 15 s maximal sprints on a cycle ergometer in normal (approximately 20 degrees C, control) and hot (40 degrees C, hyperthermia) environments. RESULTS: Completion of the intermittent protocol in the heat elevated core and muscle temperatures (39.5 +/- 0.2 degrees C; 40.2 +/- 0.4 degrees C), heart rate (178 +/- 11 beats min(-1)), rating of perceived exertion (RPE) (18 +/- 1) and noradrenaline (38.9 +/- 13.2 micromol l(-1)) (all P < 0.05). During the first sprint (n = 6), both peak and mean power output were similar across the environmental conditions. However, mean power over the last four sprints declined to a larger extent during hyperthermia compared with the control trial (P < 0.05). Consequently, average mean power output during the five sprints was lower in hyperthermia (558.0 +/- 146.9 W) compared with control (617.5 +/- 122.6 W; P < 0.05). Power output during the repeated sprints was reduced by hyperthermia despite an elevated muscle temperature that should promote sprint performance. Venous plasma potassium concentrations (H; 5.3 +/- 0.8 mmol l(-1) vs. C; 6.3 +/- 1.0 mmol l(-1), P = 0.06) and muscle lactate levels (H; 76.6 +/- 24.3 mmol kg(-1) dry weight vs. C; 108.8 +/- 20.1 mmol kg(-1) dry weight) were lower following the hyperthermic sprints compared to control. CONCLUSION: Although an elevated muscle temperature is expected to promote sprint performance, power output during the repeated sprints was reduced by hyperthermia. The impaired performance does not seem to relate to the accumulation of recognized metabolic fatigue agents and we, therefore, suggest that it may relate to the influence of high core temperature on the function of the central nervous system.

Adult↗

Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

Advances in molecular immunology over the past two decades permit a better understanding of why antibodies develop to peptide antigens like factor VIII and the events that lead to the development of these antibodies. Two important variables that are critical in antibody formation are (i) the molecular defect in FVIII and the consequences of that defect on translation and protein production, and (ii) the major histocompatibility complex (MHC) molecules which bind specific peptide sequences and present those peptides to CD4 T lymphocytes to initiate the cellular cascade leading to B-cell stimulation and differentiation, and ultimately to antibody formation. Inhibitors develop in hemophilia because transfused FVIII can be seen as a foreign protein and elicits an immune response in much the same way that any other foreign protein might elicit an immune response. However, not all hemophiliacs generate an immune response, either because they do not recognize FVIII as foreign or because their MHC phenotype is such that a cellular immune response is not initiated. In this model, it is the combination of molecular defect and MHC phenotype that determines inhibitor formation. The interplay of these two variables in the context of why some but not all hemophiliacs develop antibodies after treatment with replacement factor is reviewed.

Amino Acid Motifs↗

The correlation between Salmonella serology and isolation of Salmonella in Danish pigs at slaughter.

In Denmark, a serological Salmonella surveillance programme in finishing pig herds has been in place since 1995. The programme was founded on data from experimental studies, which demonstrated a strong association between Salmonella serology and the prevalence of these bacteria. The current study was carried out in three Danish abattoirs to evaluate the correlation under field conditions. A total of 160 Danish finishing pig herds were included. Seven out of these were examined twice, yielding a total of 167 observations. The herds were selected according to their herd serology based on data from the national surveillance. From each herd, samples were taken from 10 finishers at slaughter. The prevalence of Salmonella bacteria was measured at four sites: (1) caecal-content; (2) carcass surface; (3) pharynx; and (4) caecal lymph nodes. A logistic regression model was constructed for each sampling site. Abattoir, sanitary slaughter and herd seroprevalence were used as explanatory variables. The results demonstrated that there was a strong association between herd serology and the prevalence of Salmonella bacteria measured at three of the sampling sites: caecal-content, pharynx, and carcass surface. For these sites, the odds for being culture-positive for Salmonella varied from 1.3 to 1.5 for each increase of 10% in herd serology (P < 0.0001). For caecal lymph nodes, however, no linear association was found.

Animals↗

Exercise induces the release of heat shock protein 72 from the human brain in vivo.

The present study tested the hypothesis that in response to physical stress the human brain has the capacity to release heat shock protein 72 (Hsp72) in vivo. Therefore, 6 humans (males) cycled for 180 minutes at 60% of their maximal oxygen uptake, and the cerebral Hsp72 response was determined on the basis of the internal jugular venous to arterial difference and global cerebral blood flow. At rest, there was a net balance of Hsp72 across the brain, but after 180 minutes of exercise, we were able to detect the release of Hsp72 from the brain (335 +/- 182 ng/min). However, large individual differences were observed as 3 of the 6 subjects had a marked increase in the release of Hsp72, whereas exercise had little effect on the cerebral Hsp72 balance in the remaining 3 subjects. Given that cerebral blood flow was unchanged during exercise compared with values obtained at rest, it is unlikely that the cerebral Hsp72 release relates to necrosis of specific cells within the brain. These data demonstrate that the human brain is able to release Hsp72 in vivo in response to a physical stressor such as exercise. Further study is required to determine the biological significance of these observations.

Adult↗

Association between fatigue and failure to preserve cerebral energy turnover during prolonged exercise.

AIM: This study evaluated if the fatigue and apathy arising during exercise with hypoglycaemia could relate to a lowering of the cerebral metabolic rates of glucose and oxygen. METHODS AND RESULTS: Six males completed 3 h of cycling with or without glucose supplementation in random order. Cerebral blood flow, metabolism and interleukin-6 (IL-6) release were evaluated with the Kety-Schmidt technique. Blood glucose was maintained during the glucose trial, while it decreased from 5.2 +/- 0.1 to 2.9 +/- 0.3 mmol L-1 (mean +/- SE) after 180 min of exercise in the placebo trial with a concomitant increase in perceived exertion (P < 0.05). During hypoglycaemia, the cerebral glucose uptake was reduced from 0.34 +/- 0.05 to 0.28 +/- 0.04 micromol g(-1) min(-1), while the cerebral uptake of beta-hydroxybutyrate increased to 5 +/- 1 pmol g(-1) min(-1) (P < 0.05). The reduced glucose uptake was accompanied by a lowering of the cerebral metabolic rate of oxygen from 1.84 +/- 0.19 mmol g(-1) min(-)1 during exercise with glucose supplementation to 1.60 +/- 0.16 mmol g(-1) min(-1) during hypoglycaemia (P < 0.05). In addition, the cerebral IL-6 release was reduced from 0.4 +/- 0.1 to 0.0 +/- 0.1 pg g(-1) min(-1) (P < 0.05). CONCLUSIONS: Exercise-induced hypoglycaemia limits the cerebral uptake of glucose, exacerbates exercise, reduces the cerebral metabolic rate of oxygen and attenuates the release of IL-6 from the brain.

3-Hydroxybutyric Acid↗

Bacterial colonization and invasion in pigs experimentally exposed to Streptococcus suis serotype 2 in aerosol.

A recently developed porcine model for aerogenous infection with Streptococcus suis serotype 2 was applied in a study of the phases of bacterial colonization and initial invasion. Eighteen pigs were exposed to aerosolized S. suis serotype 2 after pre-exposure to mild acetic acid in aerosol. The animals were killed consecutively within the first six days after challenge. After death, all animals were necropsied and examined by bacteriology, histopathology, and immunohistochemistry. Systemic infection was established in four out of 18 animals exposed to S. suis serotype 2. All systemically infected animals developed clinical signs and lesions typical of the infection. In four additional animals, subclinical infection was demonstrated by re-isolation of S. suis from the palatine tonsil. However, in all 18 challenged animals, immunohistochemistry demonstrated S. suis serotype 2 antigen in the palatine and/or nasopharyngeal tonsils. In all four systemically infected animals, S. suis serotype 2 antigen was also found in the mandibular lymph node. These observations point towards the tonsils as possible portals of entry for S. suis serotype 2 with subsequent lymphogenous spread. Thus, the present findings parallel the proposed pathogenesis for S. suis serotype 1 infection in pigs.

Aerosols↗

Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.

It was recently discovered that the streptozotocin (STZ)-diabetic mouse model is characterised by GH hypersecretion in contrast to the STZ-diabetic rat, the former thus mimicking the changes in GH in human type 1 diabetes. Inhibition of circulating and renal IGF-I by long-acting somatostatin analogues reduces renal and glomerular growth and urinary albumin excretion in diabetic rats. The aim of the present study was to examine renal and glomerular growth in early experimental diabetes in mice along with changes in the GH/IGF-I axis following treatment with the somatostatin analogue octreotide. Balb/C(a) mice were randomised into non-diabetic controls, placebo-treated and octreotide-treated diabetic (50 microg/day) mice and examined 7 and 14 days after induction of diabetes. There was no effect of octreotide treatment on body weight, glycaemic control or food intake. However, octreotide treatment significantly inhibited renal and glomerular growth by the end of the study period when compared with placebo treatment. In addition, octreotide prevented an increase in kidney IGF-I by day 7. GH hypersecretion was observed in the diabetic groups but octreotide treatment reduced GH levels compared with placebo treatment by day 14. No significant differences in serum or kidney IGF-binding protein-3 levels were observed between placebo- and octreotide-treated diabetic mice. In conclusion, this new diabetic mouse model mimicking human type 1 diabetes is characterised by GH hypersecretion and the somatostatin analogue octreotide is able to prevent renal and glomerular growth, probably mediated through changes in circulating GH and local kidney IGF-I levels.

Analysis of Variance↗

Middle cerebral artery blood velocity is reduced with hyperthermia during prolonged exercise in humans.

1. In the present study we examined the effect of hyperthermia on the middle cerebral artery mean blood velocity (MCA V(mean)) during prolonged exercise. We predicted that the cerebral circulation would be impaired when hyperthermia is present during exercise and assumed that this could be observed as a reduced MCA V(mean). 2. Eight endurance trained men (maximum oxygen uptake (V(O2,max)) 70 +/- 1 ml min(-1) kg(-1) (mean +/- S.E.M.)) performed two exercise trials at 57 % of V(O2,max) on a cycle ergometer in a hot (40 degrees C; hyperthermic trial) and in a thermoneutral environment (18 degrees C; control trial). In the hyperthermic trial, the oesophageal temperature increased throughout the exercise period reaching a peak value of 40.0 +/- 0.1 degrees C at exhaustion after 53 +/- 4 min of exercise. In the control trial, exercise was maintained for 1 h without any signs of fatigue and with core temperature stabilised at 37.8 +/- 0.1 degrees C after approximately 15 min of exercise. 3. Concomitant with the development of hyperthermia, MCA V(mean) declined by 26 +/- 3 % from 73 +/- 4 cm s(-1) at the beginning of exercise to 54 +/- 4 cm s(-1) at exhaustion (P < 0.001). In contrast, MCA V(mean) remained unchanged at 70-72 cm s(-1) throughout the 1 h control trial. 4. When individually determined regression lines for MCA V(mean) and arterial carbon dioxide pressure (P(a,CO2)) obtained during preliminary exercise tests were used to account for the differences in P(a,CO2) between the hyperthermic and control trial, it appeared that more than half of the reduction in MCA V(mean) (56 +/- 8 %) was related to a hyperventilation-induced drop in P(a,CO2). Declining cardiac output and arterial blood pressure accounted for the remaining part of the hyperthermia-induced reduction in MCA V(mean). 5. The present results demonstrate that the development of hyperthermia during prolonged exercise is associated with a marked reduction in MCA V(mean).

Adult↗

[Clozapine-induced toxic hepatitis].

A case of clozapine-induced toxic hepatitis in a 49-year old woman with schizophrenia is described. The daily clozapine dose was clinically titrated to 300 mg. Subsequently, the patient experienced lethargy and anorexia, and fever, eosinophilia, leucocytosis and abnormal liver parameters were found. The serum concentration of clozapine was 8595 nmol/l, and treatment was discontinued. After eight days, the condition stabilised, and low-dose clozapine treatment was successfully reinstituted with serum monitoring (TDM).

Chemical and Drug Induced Liver Injury↗

Synthesis and pharmacology of 3-isoxazolol amino acids as selective antagonists at group I metabotropic glutamic acid receptors.

Using ibotenic acid (2) as a lead, two series of 3-isoxazolol amino acid ligands for (S)-glutamic acid (Glu, 1) receptors have been developed. Whereas analogues of (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid [AMPA, (RS)-3] interact selectively with ionotropic Glu receptors (iGluRs), the few analogues of (RS)-2-amino-3-(3-hydroxy-5-isoxazolyl)propionic acid [HIBO, (RS)-4] so far known typically interact with iGluRs as well as metabotropic Glu receptors (mGluRs). We here report the synthesis and pharmacology of a series of 4-substituted analogues of HIBO. The hexyl analogue 9 was shown to be an antagonist at group I mGluRs. The effects of 9 were shown to reside exclusively in (S)-9 (K(b) = 30 microM at mGlu(1) and K(b) = 61 microM at mGlu(5)). The lower homologue of 9, compound 8, showed comparable effects at mGluRs, but 8 also was a weak agonist at the AMPA subtype of iGluRs. Like 9, the higher homologue, compound 10, did not interact with iGluRs, but 10 selectively antagonized mGlu(1) (K(b) = 160 microM) showing very weak antagonist effect at mGlu(5) (K(b) = 990 microM). The phenyl analogue 11 turned out to be an AMPA agonist and an antagonist at mGlu(1) and mGlu(5), and these effects were shown to originate in (S)-11 (EC(50) = 395 microM, K(b) = 86 and 90 microM, respectively). Compound 9, administered icv, but not sc, was shown to protect mice against convulsions induced by N-methyl-D-aspartic acid (NMDA). Compounds 9 and 11 were resolved using chiral HPLC, and the configurational assignments of the enantiomers were based on X-ray crystallographic analyses.

Amino Acids↗

Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.

(RS)-2-Amino-3-(5-tert-butyl-3-hydroxy-4-isothiazolyl)propionic acid (thio-ATPA), a 3-isothiazolol analogue of (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), has previously been shown to be a relatively weak AMPA receptor agonist at native (S)-glutamic acid ((S)-Glu) receptors (EC(50)=14 microM), comparable in potency with ATPA (EC(50)=34 microM). Recent findings, that (S)-ATPA is a potent (EC(50)=0.48 microM) and selective agonist at homomerically expressed ionotropic GluR5, prompted us to resolve thio-ATPA using chiral chromatography and pharmacologically characterize the two enantiomers at native as well as cloned ionotropic glutamate receptors. The enantiomers, (S)- and (R)-thio-ATPA, were obtained in high enantiomeric excess, and their absolute stereochemistry established by an X-ray crystallographic analysis. Electrophysiologically, the two enantiomers were evaluated in the rat cortical wedge preparation, and the S-enantiomer was found to be an AMPA receptor agonist (EC(50)=8.7 microM) twice as potent as the racemate, whereas the R-enantiomer was devoid of activity. In accordance with this, (S)-thio-ATPA proved to be an agonist at homomerically expressed recombinant AMPA receptors (GluR1o, GluR3o, and GluR4o) with EC(50) values of 5, 32 and 20 microM, respectively, producing maximal steady state currents of 78--168% of those maximally evoked by kainic acid, and 120-1600% of those maximally evoked by (S)-ATPA. At homomerically expressed GluR5, (S)-thio-ATPA was found to be a potent agonist (EC(50)=0.10 microM), thus being approximately five times more potent than (S)-ATPA. (R)-Thio-ATPA induced saturating currents with an estimated EC(50) value of 10 microM, most likely due to a contamination with (S)-thio-ATPA. At heteromerically expressed GluR6+KA2 receptors, (S)-thio-ATPA showed relatively weak agonistic properties (EC(50)=4.9 microM). Thus, (S)-thio-ATPA has been shown to be a very potent agonist at GluR5, and may be a valuable tool for the investigation of desensitization properties of AMPA receptors.

Alanine↗

Resolution, configurational assignment, and enantiopharmacology at glutamate receptors of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) and demethyl-ACPA.

We have previously described (RS)-2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) as a potent agonist at the (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor subtype of (S)-glutamic acid (Glu) receptors. We now report the chromatographic resolution of ACPA and (RS)-2-amino-3-(3-carboxy-4-isoxazolyl)propionic acid (demethyl-ACPA) using a Sumichiral OA-5000 column. The configuration of the enantiomers of both compounds have been assigned based on X-ray crystallographic analyses, supported by circular dichroism spectra and elution orders on chiral HPLC columns. Furthermore, the enantiopharmacology of ACPA and demethyl-ACPA was investigated using radioligand binding and cortical wedge electrophysiological assay systems and cloned metabotropic Glu receptors. (S)-ACPA showed high affinity in AMPA binding (IC(50) = 0.025 microM), low affinity in kainic acid binding (IC(50) = 3.6 microM), and potent AMPA receptor agonist activity on cortical neurons (EC(50) = 0.25 microM), whereas (R)-ACPA was essentially inactive. Like (S)-ACPA, (S)-demethyl-ACPA displayed high AMPA receptor affinity (IC(50) = 0.039 microM), but was found to be a relatively weak AMPA receptor agonist (EC(50) = 12 microM). The stereoselectivity observed for demethyl-ACPA was high when based on AMPA receptor affinity (eudismic ratio = 250), but low when based on electrophysiological activity (eudismic ratio = 10). (R)-Demethyl-ACPA also possessed a weak NMDA receptor antagonist activity (IC(50) = 220 microM). Among the enantiomers tested, only (S)-demethyl-ACPA showed activity at metabotropic receptors, being a weak antagonist at the mGlu(2) receptor subtype (K(B) = 148 microM).

Alanine↗

Brain activity and fatigue during prolonged exercise in the heat.

We hypothesized that fatigue due to hyperthermia during prolonged exercise in the heat is in part related to alterations in frontal cortical brain activity. The electroencephalographic activity (EEG) of the frontal cortex of the brain was measured in seven cyclists [maximal O2 uptake (VO2max) 4.8 +/- 0.1 (SE) 1 min-1] cycling at 60% VO2max in a hot (H, 42 degrees C) and a cool (C, 19 degrees C) environment. Fast Fourier transformation of the EEG was used to obtain power spectrum areas in the alpha (8-13 Hz) and beta (13-30 Hz) frequencies. The ratio alpha/beta was calculated as an index of arousal level; an elevated alpha/beta index reflects suppressed arousal. In H, subjects fatigued after 34.4 +/- 1.4 min coinciding with an oesophageal temperature (Toes) of 39.8 +/- 0.1 degrees C, an almost maximal heart rate (HR 192 +/- 3 beats.min-1), a rating of perceived exertion (RPE) of 19.0 +/- 0.8 and significantly elevated alpha/beta index (188 +/- 71% of the value after 2 min of exercise; P < 0.05). In C, subjects cycled for a similar period while Toes was below 38 degrees C, HR and RPE were low, and the alpha/beta index was not significantly elevated (59 +/- 27% of 2 min value; P = NS). Increases in the alpha/beta index were strongly correlated to increases in Toes (r2 = 0.98; P = 0.0001).

Adult↗

Temperature responses to electrically induced cycling in spinal cord injured persons.

PURPOSE: The purpose of the study was to investigate the core temperature responses to the induction of electrical exercise and to clarify whether an increase in temperature could be responsible for some of the observed reactions to acute and repeated exposure to electrical muscle stimulation. METHODS: The paralyzed thigh and gluteal muscles were stimulated electrically with surface electrodes in seven persons with transection of the spinal cord. By this means, they were able to pedal a lower extremity ergometer at 50 revolutions per minute for 30 min. Skin surface, esophageal (Tes), rectal (Tre), and muscle temperature in m. quadriceps were measured with thermocouples. RESULTS: The average rate of oxygen consumption was 0.91 +/- 0.16 L.min-1, and the heart rate after 20 min was 123 +/- 9 bpm during the electrically induced exercise. The involuntary, induced exercise led to increases in core temperature, whereas skin surface temperature was the same before and after exercise. Average Tes and Tre both rose 0.7 degrees C from, respectively, 36.6 +/- 0.2 and 36.9 +/- 0.1 degrees C, and muscle temperature increased even more: 2.9 degrees C from 33.9 +/- 0.3 degrees C. CONCLUSION: It is suggested that these increased temperatures may act as stimuli, directly or, through resulting release of humoral factors, and elicit the changes in heart rate, as well as the previously observed adaptive changes after electrically induced exercise, e.g., in muscle fiber size, and capillarization.

Adaptation, Physiological↗

Effects of marked hyperthermia with and without dehydration on VO(2) kinetics during intense exercise.

This study determined whether marked hyperthermia alone or in combination with dehydration reduces the initial rate of rise in O(2) consumption (VO(2) on-kinetics) and the maximal rate of O(2) uptake (VO(2 max)) during intense cycling exercise. Six endurance-trained male cyclists completed four maximal cycle ergometer exercise tests (402 +/- 4 W) when euhydrated or dehydrated (4% body wt) with normal (starting esophageal temperature, 37.5 +/- 0.2 degrees C; mean skin temperature, approximately 31 degrees C) or elevated (+1 and +6 degrees C, respectively) thermal strain. In the euhydrated and normal condition, subjects reached VO(2 max) (4.7 +/- 0.2 l/min) in 228 +/- 34 s, with a mean response time of 42 +/- 2 s, and fatigued after 353 +/- 39 s. Hyperthermia alone or in combination with dehydration reduced mean response time (17-23%), VO(2 max) (16%), and performance time (51-53%) (all P < 0.01) but did not alter the absolute response time (i.e., the time to reach 63% response in the control trial, 3.2 +/- 0.1 l/min, 42 s). Reduction in VO(2 max) was accompanied by proportional decline in O(2) pulse and significantly elevated maximal heart rate (195 vs. 190 beats/min for hyperthermia vs. normal). Preventing hyperthermia in dehydrated subjects restored VO(2 max) and performance time by 65 and 50%, respectively. These results demonstrate that impaired high-intensity exercise performance with marked skin and internal body hyperthermia alone or in combination with dehydration is not associated with a diminished rate of rise in VO(2) but decreased VO(2 max).

Adult↗